Home Link (JNJ Logo) Change Country Johnson & Johnson Announces Plans to Separate Consumer Health Business Learn More alt Share LATEST NEWS How Johnson & Johnson Is Helping Tackle a Devastating Tropical Disease That Impacts Kids A new World Health Organization prequalification for mebendazole means the company can reach even more young people with intestinal worm infections around the globe. By Johnson & JohnsonApril 09, 2019 STH. It's an illness you likely haven't heard of, yet it affects approximately 1.5 billion people worldwide, making it one of the world's most common infections. It's short for soil-transmitted helminthiasis, also known as intestinal worm infections, and it results from being exposed to contaminated soil, food or water in areas with poor sanitation. Children are particularly vulnerable to STH, which can lead to malnutrition, stunted growth and even impaired cognitive development. Caring & Giving Around the Globe: 43 Johnson & Johnson Programs That Are Transforming Lives—and the Future of Healthcare Now, the World Health Organization (WHO) has prequalified a new way to protect children ages 1 and older against this neglected tropical disease (NTD) around the globe: a formulation of a worm-fighting medication called mebendazole that can either be chewed or mixed with a small amount of water to form a soft mass that's easier for very young children to swallow. “As part of Johnson & Johnson’s long-standing commitment to combat NTDs, the Janssen Pharmaceutical Companies of Johnson & Johnson developed this safe and effective pediatric formulation,” says Paul Stoffels, M.D. , Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson. “The WHO prequalification of this easier-to-swallow formulation is a critical step in our efforts to help young children suffering from devastating diseases.” The chewable formulation is also useful for older children and adults who need treatment for STH, particularly in communities that have limited access to clean water. Since 2006, Johnson & Johnson has delivered more than 1.4 billion doses of its parasite-fighting medication to approximately 800 million children worldwide. The company will begin distributing the new pediatric formulation as part of its donations this year. Johnson & Johnson's Long Commitment to Helping Fight STH Since 2006, Johnson & Johnson has delivered more than 1.4 billion doses of its parasite-fighting medication to approximately 800 million children worldwide. Six years later, the company joined other pharmaceutical companies and organizations, including the Bill & Melinda Gates Foundation, to endorse the London Declaration on Neglected Tropical Diseases—a landmark pledge to donate existing treatments and develop new tools to help combat these illnesses. Johnson & Johnson Earns a Top Spot on the 2018 Access to Medicine Index At that time, Johnson & Johnson committed to giving 200 million doses of its medication annually through 2020 via a donation program operated by the WHO. The company just extended that commitment another five years and will donate an additional one billion doses of the medication for high-burden countries starting in 2021 and going through 2025. Additionally, with the WHO prequalification, the company will begin distributing the new pediatric formulation as part of its donations this year, with a full transition to the chewable tablets starting in 2020. “Beyond drug donations, we are also actively collaborating with partners to improve STH diagnostics, monitoring and evaluation to allow for better data collection and decision-making,” says Jaak Peeters , Head of Johnson & Johnson Global Public Health, Janssen-Cilag GmbH. “We want to help the global health community identify sustainable, long-term solutions to reduce the prevalence of intestinal worms in children and adults alike.” Johnson & Johnson's Commitment to Global Public Health Read about the company's efforts to help solve unmet global health challenges, from delivering care to underserved populations to pioneering the next generation of treatment solutions. Learn more Caring & Giving Innovation Johnson & Johnson Janssen Intestinal worms Global Public Health More from Johnson & Johnson INNOVATION November 18, 2021 How Johnson & Johnson is Using Technology To Revolutionize the Way We Live and Work alt How Johnson & Johnson is Using Technology To Revolutionize the Way We Live and Work LATEST NEWS November 11, 2021 Johnson & Johnson COVID-19 Vaccine Named One of Time's Best Inventions of 2021 alt Johnson & Johnson COVID-19 Vaccine Named One of 's Best Inventions of 2021 PERSONAL STORIES November 03, 2021 "I Want to Live a Life That's Not Defined By My Schizophrenia" "I Want to Live a Life That's Not Defined By My Schizophrenia" QUICK LINKS Latest News Careers Privacy Policy About J&J Media Center Cookie Policy Legal Notice Products Investors Employees Procurement Our Societal Impact Contact Us Credo Integrity Line MORE FROM JOHNSON & JOHNSON Janssen Janssen Pharmaceutical Companies of Johnson & Johnson Johnson & Johnson Medical Devices Companies Johnson & Johnson Medical Devices Companies Reimagining the Way Healthcare Is Delivered Johnson & Johnson Consumer Health Johnson & Johnson Consumer Health Meeting the Personal Care and Wellness Needs of Consumers Worldwide Our Consumer Safety and Care Commitment Our Consumer Safety and Care Commitment Your Safety Is Our Priority Johnson & Johnson Innovation Johnson & Johnson Innovation Advancing New Healthcare Solutions Through Collaboration Johnson & Johnson Our Story Johnson & Johnson Our Story Learn About the Company's Rich Heritage at Our Digital Museum FOLLOW US Facebook facebook Instagram instagram LinkedIn linkedin Twitter twitter YouTube youtube This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information. Do Not Sell My Personal Information All contents © Copyright Johnson & Johnson Services, Inc.1997-2021. All Rights Reserved. This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies. Accept